7

Aim:To evaluate the effectiveness and predictive value of a monophasic oral preparation containing micronized gestodene and ethinylestradiol in the treatment of COVID-19-associated menstrual-ovarian dysfunction in women of different reproductive ages.Methods:The study included 120 women of various reproductive ages with COVID-19-associated dysfunctions who underwent a 3-month rehabilitation therapy using a combined oral contraceptive (0.060 mg gestodene + 0.015 mg ethinylestradiol). Restoration of menstrual-ovarian function, ovulation, fertility, and endometrial ER and PR receptor expression were assessed; the risk of recurrence was calculated using a predictive model.Results:Restoration rates of menstrual-ovarian function were: 82.5% in early, 76.1% in middle, and 70.1% in late reproductive age. Fertility recovery rates were 72.3%, 65.6%, and 60.3%, respectively. Repeated immunohistochemical analysis showed ER expression increased to 86% and PR to 85.4%. The predictive model for recurrence risk had an ROC AUC of 0.85.Conclusion:Monophasic therapy with micronized gestodene and ethinylestradiol is highly effective in eliminating COVID-19-associated menstrual-ovarian dysfunction. Endometrial ER and PR expression is improved, and the recurrence risk predictionmodel shows high accuracy. This personalized approach is recommended as an effective and reliable method in clinical practice for such patients

  • Read count 7
  • Date of publication 10-06-2025
  • Main LanguageIngliz
  • Pages 162-170
English

Aim:To evaluate the effectiveness and predictive value of a monophasic oral preparation containing micronized gestodene and ethinylestradiol in the treatment of COVID-19-associated menstrual-ovarian dysfunction in women of different reproductive ages.Methods:The study included 120 women of various reproductive ages with COVID-19-associated dysfunctions who underwent a 3-month rehabilitation therapy using a combined oral contraceptive (0.060 mg gestodene + 0.015 mg ethinylestradiol). Restoration of menstrual-ovarian function, ovulation, fertility, and endometrial ER and PR receptor expression were assessed; the risk of recurrence was calculated using a predictive model.Results:Restoration rates of menstrual-ovarian function were: 82.5% in early, 76.1% in middle, and 70.1% in late reproductive age. Fertility recovery rates were 72.3%, 65.6%, and 60.3%, respectively. Repeated immunohistochemical analysis showed ER expression increased to 86% and PR to 85.4%. The predictive model for recurrence risk had an ROC AUC of 0.85.Conclusion:Monophasic therapy with micronized gestodene and ethinylestradiol is highly effective in eliminating COVID-19-associated menstrual-ovarian dysfunction. Endometrial ER and PR expression is improved, and the recurrence risk predictionmodel shows high accuracy. This personalized approach is recommended as an effective and reliable method in clinical practice for such patients

№ Name of reference
1 1.Adamyan L.V., Aznaurova Ya.B., Filippov O.S. COVID-19 and women's health (literature review). Problems of Reproduction. 2020;26(2):6–17. (in Russian)2.Belokrinitskaya T.E., Frolova N.I., Mudrov V.A., Kargina K.A., Shametova E.A., Zhamyanova Ch.Ts., OsmonovaSh.R. Post-COVID syndrome in young healthy women: myth or reality? Gynecology. 2023;25(3):341–347. (in Russian)3.Bitsadze V.O., Khizroeva D.Kh., Makatsaria A.D., Slukhanchuk E.V., Tretyakova M.V., et al. COVID-19, septic shock, and DIC syndrome. Bulletin of RAMS. 2020;75(3):214–225. (in Russian)4.Gorbacheva T.I., Nikolaeva M.G., Stroganov A.E., Orlova O.V., Khoreva L.A., Uvarova Yu.M., Denisyuk E.A., Olovyannikov Yu.S. Menstrual function and mental health of medical university students during the COVID-19 pandemic. Gynecology. 2023;25(3):320–327. (in Russian)5.Dovgan A.A., Drapkina Yu.S., Dolgushina N.V., Menzhinskaya I.V., Inviyaeva E.V., Vtorushina V.V., Krechetova L.V., Sukhikh G.T. The effect of COVID-19 vaccination on immune status and autoantibody profile in women of reproductive age. Medical Immunology. 2022;24(5):979–992. (in Russian)6.Dolgushina N.V., Dovgan A.A., Drapkina Yu.S., Ivanets T.Yu., Vtorushina V.V., Gus A.I., Sukhikh G.T. Effects of a domestic vector vaccine against COVID-19 on ovarian reserve and menstrual function in reproductive-age women. Obstetrics and Gynecology. 2022;(4):115–122. (in Russian)7.Zhmerenetsky K.V., Sazonova E.N., Voronina N.V., Tomilka G.S., Senkevich O.A., Gorokhovsky V.S., Kutsy M.B. COVID-19: only scientific facts. Far Eastern Medical Journal. 2020;(1):5–22. (in Russian)8.Zatvornitskaya A.V., Kazachkov E.L., Kazachkova E.A., Voropaeva E.E. Association of COVID-19 and endometrial pathology (literature review). Journal of Siberian Medical Sciences. 2024;8(2):114–126. (in Russian)9.Kashapova E.F., Polyanskaya A.K., Zvychainy M.A. The impact of COVID-19 on menstrual and reproductive function in women. Actual Problems of Modern Medical Science and Healthcare. 2022:150–155. (in Russian)10.Klimchuk A.V., Beloglazov V.A., Yatskov I.A., Dvoryanchikov Ya.V. Endocrine disorders during and after COVID-19. Obesity and Metabolism. 2022;19(2):206–212. (in Russian)11.Maltseva A.N. The impact of COVID-19 on menstrual function in reproductive-age women. RMJ. Mother and Child. 2022;5(2):112–117. (in Russian)12.Mozheyko L.F., Markova E.D. Correction of menstrual disorders after COVID-19 infection. Reproductive Health. 2022;12(3):301–308. (in Russian)13.Parfyonova Ya.A., Shibelgut N.M., Artymyuk N.V. Impact of COVID-19 on reproductive health in women. Mother and Child in Kuzbass. 2021;(3):36–40. (in Russian)14.Svidinskaya E.A., Ageev M.B., Paleeva N.V., Mukhaeva V.A., Sosnova E.A. Menstrual disorders in overweight adolescent girls (literature review). Archives of Obstetrics and Gynecology named after V.F. Snegirev. 2022;9(2):93–101. (in Russian)15.Khadzhieva N.Kh., Kuznetsov A.I. The COVID-19 pandemic in the context of women's reproductive health. Women’s Clinic. (2):43–52. (in Russian)16.Ahmed B., Etman M., Sofian S.M., Sobhy B.M., Abd El-Salam A.E.M., El Sherbiny A. The Effect of COVID-19 Disease on Ovarian Reserve in Women of Reproductive Age: An Analytical Before-and-After Study. 2022:1–14.17.AlBdairi A.A., Makki H.A., Shawki O., et al. The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review. Cureus. 2024;16(4):e57944.18.Alvergne A., Kountourides G., Argentieri M.A., et al. Menstrual cycle changes following COVID-19 vaccination and disease: a retrospective case-control study. iScience. 2023;26(4):106401.19.Ata B., Vermeulen N., Mocanu E., et al. SARS-CoV-2, fertility and assisted reproduction. Human Reproduction Update. 2023;29(2):177–196.20.Basile G., Billone V., Umani R.F. COVID-19 and its aftermath: new drivers of infertility? Clinical Therapeutics. 2023;174(4):343–344.21.Cherenack E.M., Salazar A.S., Nogueira N.F., et al. Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age. PLoS One. 2022;17(10).22.Farland L.V., Khan S.M., Shilen A., et al. COVID-19 vaccination and menstrual cycle changes among vaccinated persons. Fertility and Sterility. 2023;119(3):392–400.23.Granja M.G., Oliveira A.C.D.R., Figueiredo C.S., et al. SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface. Neuroimmunomodulation. 2021;28(1):1–21.24.Li F., Lu H., Zhang Q., et al. Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol. BMJ Open. 2021;11.25.Li J., Bai J., Xiang X., et al. Effect of COVID-19 on menstruation and lower reproductive tract health. International Journal of Women's Health. 2023;15:1999–2013.26.Li S., Liu H., Li D., Chen F. Female reproductive health during the COVID-19 pandemic: latest evidence and understanding. Archives of Gynecology and Obstetrics. 2023;308(6):1691–1696.27.Maher M., Keeffe A., Phelan N., et al. Female reproductive health disturbance during the COVID-19 pandemic correlates with mental health disturbance and sleep quality. Frontiers in Endocrinology. 2022;13:838886.28.Maybin J.A., Watters M., Rowley B., et al. COVID-19 and abnormal uterine bleeding: potential associations and mechanisms. Clinical Science (London). 2024;138(4):153–171.29.Mitra A., Verbakel J.Y., Kasaven L.S., et al. The menstrual cycle and the COVID-19 pandemic. PLoS One. 2023;18(10).30.WesselinkA.K., Lovett S.M., Weinberg J., et al. COVID-19 vaccination and menstrual cycle characteristics: a prospective cohort study. Vaccine. 2023;41(29):4327–4334.
Waiting